Born has acted as legal adviser to LifeClean International AB (publ), whose shares are listed on Nasdaq First North Growth Market, in connection with the company’s entry into a partnership and exclusive distribution agreement for LifeClean’s disinfection products with Arxada AG, a global company headquartered in Switzerland.
The agreement enables LifeClean to expand its distribution reach and access new markets, supporting the company’s growth and development. Under the partnership, Arxada has been granted exclusive rights to commercialise and distribute LifeClean’s disinfection products within the healthcare sector in the European Union, Switzerland, the United Kingdom, Northern Ireland, and Ukraine.




